[A case of hepatocellular carcinoma treated by transcatheter arterial chemoembolization and hepatectomy after subtotal stomach preserving pancreaticoduodenectomy for duodenal cancer].

Sakae Maeda, Hiroshi Wada, Masahiro Tanemura, Shogo Kobayashi, Koichi Kawamoto, Shigeru Marubashi, Hidetoshi Eguchi, Koji Umeshita, Yuichiro Doki, Masaki Mori, Hiroaki Nagano

Research output: Contribution to journalArticle

Abstract

Treatments for hepatocellular carcinoma(HCC) including surgical resection, transcatheter arterial chemoembolization (TACE), percutaneous local therapy, and systemic chemotherapy are decided upon according to tumor progression and liver function. However, it is difficult to choose a treatment after biliary tract reconstruction. Here we report a case of successful treatment for HCC and its recurrence where there had also been subtotal stomach preserving pancreaticoduodenectomy(SSPPD) for duodenal cancer. A 65-year-old female patient who had undergone SSPPD for duodenal cancer was found to have HCC in segment 8 (S8) 12 months later. Three months after super selective TACE, S8 partial resection was performed approaching through right thoracotomy and laparotomy. 2 years after the first hepatectomy, HCC was found to have reoccurred in S7/8 and S8. Right hepatic lobectomy was then performed without blocking the hepatic hilum. Liver resection was carried out with the aim of achieving A-P point. In this case then, several radical treatments have been completed without any biliary complication.

Original languageEnglish
Pages (from-to)1988-1990
Number of pages3
JournalGan to kagaku ryoho. Cancer & chemotherapy
Volume39
Issue number12
Publication statusPublished - Jan 1 2012
Externally publishedYes

Fingerprint

Duodenal Neoplasms
Pancreaticoduodenectomy
Hepatectomy
Hepatocellular Carcinoma
Stomach
Liver
ethyl-2-methylthio-4-methyl-5-pyrimidine carboxylate
Therapeutics
Biliary Tract
Thoracotomy
Laparotomy
Recurrence
Drug Therapy
Neoplasms

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

[A case of hepatocellular carcinoma treated by transcatheter arterial chemoembolization and hepatectomy after subtotal stomach preserving pancreaticoduodenectomy for duodenal cancer]. / Maeda, Sakae; Wada, Hiroshi; Tanemura, Masahiro; Kobayashi, Shogo; Kawamoto, Koichi; Marubashi, Shigeru; Eguchi, Hidetoshi; Umeshita, Koji; Doki, Yuichiro; Mori, Masaki; Nagano, Hiroaki.

In: Gan to kagaku ryoho. Cancer & chemotherapy, Vol. 39, No. 12, 01.01.2012, p. 1988-1990.

Research output: Contribution to journalArticle

Maeda, S, Wada, H, Tanemura, M, Kobayashi, S, Kawamoto, K, Marubashi, S, Eguchi, H, Umeshita, K, Doki, Y, Mori, M & Nagano, H 2012, '[A case of hepatocellular carcinoma treated by transcatheter arterial chemoembolization and hepatectomy after subtotal stomach preserving pancreaticoduodenectomy for duodenal cancer].', Gan to kagaku ryoho. Cancer & chemotherapy, vol. 39, no. 12, pp. 1988-1990.
Maeda, Sakae ; Wada, Hiroshi ; Tanemura, Masahiro ; Kobayashi, Shogo ; Kawamoto, Koichi ; Marubashi, Shigeru ; Eguchi, Hidetoshi ; Umeshita, Koji ; Doki, Yuichiro ; Mori, Masaki ; Nagano, Hiroaki. / [A case of hepatocellular carcinoma treated by transcatheter arterial chemoembolization and hepatectomy after subtotal stomach preserving pancreaticoduodenectomy for duodenal cancer]. In: Gan to kagaku ryoho. Cancer & chemotherapy. 2012 ; Vol. 39, No. 12. pp. 1988-1990.
@article{1c9b87b830254f85ba6e5c1cebc6805d,
title = "[A case of hepatocellular carcinoma treated by transcatheter arterial chemoembolization and hepatectomy after subtotal stomach preserving pancreaticoduodenectomy for duodenal cancer].",
abstract = "Treatments for hepatocellular carcinoma(HCC) including surgical resection, transcatheter arterial chemoembolization (TACE), percutaneous local therapy, and systemic chemotherapy are decided upon according to tumor progression and liver function. However, it is difficult to choose a treatment after biliary tract reconstruction. Here we report a case of successful treatment for HCC and its recurrence where there had also been subtotal stomach preserving pancreaticoduodenectomy(SSPPD) for duodenal cancer. A 65-year-old female patient who had undergone SSPPD for duodenal cancer was found to have HCC in segment 8 (S8) 12 months later. Three months after super selective TACE, S8 partial resection was performed approaching through right thoracotomy and laparotomy. 2 years after the first hepatectomy, HCC was found to have reoccurred in S7/8 and S8. Right hepatic lobectomy was then performed without blocking the hepatic hilum. Liver resection was carried out with the aim of achieving A-P point. In this case then, several radical treatments have been completed without any biliary complication.",
author = "Sakae Maeda and Hiroshi Wada and Masahiro Tanemura and Shogo Kobayashi and Koichi Kawamoto and Shigeru Marubashi and Hidetoshi Eguchi and Koji Umeshita and Yuichiro Doki and Masaki Mori and Hiroaki Nagano",
year = "2012",
month = "1",
day = "1",
language = "English",
volume = "39",
pages = "1988--1990",
journal = "Japanese Journal of Cancer and Chemotherapy",
issn = "0385-0684",
publisher = "Japanese Journal of Cancer and Chemotherapy Publishers Inc.",
number = "12",

}

TY - JOUR

T1 - [A case of hepatocellular carcinoma treated by transcatheter arterial chemoembolization and hepatectomy after subtotal stomach preserving pancreaticoduodenectomy for duodenal cancer].

AU - Maeda, Sakae

AU - Wada, Hiroshi

AU - Tanemura, Masahiro

AU - Kobayashi, Shogo

AU - Kawamoto, Koichi

AU - Marubashi, Shigeru

AU - Eguchi, Hidetoshi

AU - Umeshita, Koji

AU - Doki, Yuichiro

AU - Mori, Masaki

AU - Nagano, Hiroaki

PY - 2012/1/1

Y1 - 2012/1/1

N2 - Treatments for hepatocellular carcinoma(HCC) including surgical resection, transcatheter arterial chemoembolization (TACE), percutaneous local therapy, and systemic chemotherapy are decided upon according to tumor progression and liver function. However, it is difficult to choose a treatment after biliary tract reconstruction. Here we report a case of successful treatment for HCC and its recurrence where there had also been subtotal stomach preserving pancreaticoduodenectomy(SSPPD) for duodenal cancer. A 65-year-old female patient who had undergone SSPPD for duodenal cancer was found to have HCC in segment 8 (S8) 12 months later. Three months after super selective TACE, S8 partial resection was performed approaching through right thoracotomy and laparotomy. 2 years after the first hepatectomy, HCC was found to have reoccurred in S7/8 and S8. Right hepatic lobectomy was then performed without blocking the hepatic hilum. Liver resection was carried out with the aim of achieving A-P point. In this case then, several radical treatments have been completed without any biliary complication.

AB - Treatments for hepatocellular carcinoma(HCC) including surgical resection, transcatheter arterial chemoembolization (TACE), percutaneous local therapy, and systemic chemotherapy are decided upon according to tumor progression and liver function. However, it is difficult to choose a treatment after biliary tract reconstruction. Here we report a case of successful treatment for HCC and its recurrence where there had also been subtotal stomach preserving pancreaticoduodenectomy(SSPPD) for duodenal cancer. A 65-year-old female patient who had undergone SSPPD for duodenal cancer was found to have HCC in segment 8 (S8) 12 months later. Three months after super selective TACE, S8 partial resection was performed approaching through right thoracotomy and laparotomy. 2 years after the first hepatectomy, HCC was found to have reoccurred in S7/8 and S8. Right hepatic lobectomy was then performed without blocking the hepatic hilum. Liver resection was carried out with the aim of achieving A-P point. In this case then, several radical treatments have been completed without any biliary complication.

UR - http://www.scopus.com/inward/record.url?scp=84875902966&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875902966&partnerID=8YFLogxK

M3 - Article

VL - 39

SP - 1988

EP - 1990

JO - Japanese Journal of Cancer and Chemotherapy

JF - Japanese Journal of Cancer and Chemotherapy

SN - 0385-0684

IS - 12

ER -